The results indicated that in the group treated with BLM and Conodin A, the protein expression levels of GRP78 and ATF6 were significantly elevated compared to BLM treatment alone, while the expression level of XBP1u was notably decreased, and the expression level of c-cas3 was markedly increased (Fig. 6C). This evidence concerns the gene ATF6 and Bloom syndrome.